Up next

Autoplay

GRACEcast-084_Lung-Cancer_ALK Inhibition: Science and Early Clinical Experience by Dr. Ben Solomon

6 Views • 07/30/23
Share
Embed
administrator
administrator
Subscribers
0

http://cancergrace.org/

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay